Ventoxen-100mg-Venetoclax

Ventoxen-100mg-Venetoclax Description:

Ventoxen-100mg is a medication used to treat adults with Chronic Lymphocytic leukemia (CLL), small lymphocytic leukemia, and acute myeloid leukemia. It is sold under the brand names Venclexta and Venclyxto.

Ventoxen-100mg-Venetoclax Indication:

• Ventoxen 100mg is used to treat newly diagnosed acute myeloid leukemia (AML) in combination with other medications like azacitidine.
• It is also used to treat chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia in adults in combination with other medication like rituximab.

Ventoxen (Venetoclax) Mechanism of Action:

Ventoxen-100mg-Venetoclax is a BCL-2 inhibitor that works by blocking the protein BCL-2.  This protein helps cancer cells survive by preventing programmed cell death. It is particularly effective against cancer cells that overexpress BCL-2. Which is common in blood cancers like chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).

Ventoxen-100mg can be taken alone or in combination with other chemotherapy drugs, making chemotherapy more effective and reducing side effects.

Dosage and Absorption of Venetoclax

Dosage for chronic lymphocytic leukemia and small lymphocytic leukemia:

Week 1: 20 mg daily

2: 50 mg daily

3: 100 mg daily

4: 200 mg daily

5 and further: 400mg daily

Dosage for acute myeloid leukemia:

Day 2Day 1: 100mg daily

Day-2: 200mg daily

Day-3 and further: 400 mg daily

Side Effects of Ventoxen (Venetoclax)

Ventoxen-100mg-Venetoclax is a medication that can cause various side effects, including

• nausea
• vomiting
• fatigue
• diarrhea
• constipation
• muscle and joint pain
• headache
• dizziness
• fever
• and insomnia.

It can also cause more serious side effects like tumor lysis syndrome (TLS), neutropenia, thrombocytopenia, and sepsis. These side effects can vary depending on the individual patient and are usually manageable once the drug is stopped. It is crucial to consult a doctor about potential side effects and how they can be managed to ensure the safe and effective use of venetoclax.

FDA Approval for Venetoclax

FDA has approved venetoclax to treat acute myeloid leukemia in adults on November 21, 2018, CLL and SLL on May 15, 2019, CLL or SLL with or without 17p deletion on June 8, 2018, and last newly diagnosed AML in December 30, 2021.

Ventoxen 100 mg price

Ventoxen 100mg will cost $400 USD. It is manufactured in Bangladesh by Everest pharma. If you want to buy this medication just send us a text on WhatsApp mentioning your quantity and location we may discuss it further there. We are also available in Facebook, WeChat, Instagram, Linked in.

Azacytidine Venetoclax:

Azacytidine and venetoclax are chemotherapy drugs used in combination to treat acute myeloid leukemia (AML). Venetoclax, a BCL-2 inhibitor, blocks BCL-2 protein, killing cancer cells. The combination has been effective, especially in older patients and those with comorbidities. A large clinical trial achieved a complete remission rate of 73% in patients 75 years or older.

Survival rate of venetoclax

The survival rate for patients with advanced myeloid leukemia (AML) treated with venetoclax varies based on factors like age, health, and AML stage. However, venetoclax is effective, with high response rates and improved survival rates compared to other treatments. A large clinical trial found a median overall survival of 14.7 months for patients aged 75 or older or with comorbidities that prevent intensive chemotherapy. In a separate trial, venetoclax achieved a median overall survival of 7.2 months in relapsed or refractory AML patients. While venetoclax is not a cure, it can significantly improve survival and quality of life for AML patients.

There are others medicine also for the treatment of leukemia, axinix 5mg Ibrutinib, Eltrombopag, Avatrombopag, Ivosenib 250mg,

you also may have a look for diabetic and weight loss medication FITARO